scholarly journals Reader response: INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease

Neurology ◽  
2020 ◽  
Vol 94 (13) ◽  
pp. 593.2-594
Author(s):  
J. Wesson Ashford
Keyword(s):  
Alzheimer Disease ◽  
Randomized Trial ◽  
Reader Response ◽  
Slow Progress

A Pilot Randomized Trial of Carbamazepine for Behavioral Symptoms in Treatment-Resistant Outpatients with Alzheimer Disease

2001 ◽  
Vol 9 (4) ◽  
pp. 400-405 ◽  
Author(s):  
Jason T. Olin ◽  
Lauren S. Fox ◽  
Sonia Pawluczyk ◽  
Nansi A. Taggart ◽  
Lon S. Schneider
Keyword(s):  
Alzheimer Disease ◽  
Randomized Trial ◽  
Behavioral Symptoms ◽  
Treatment Resistant

scholarly journals A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease

Neurology ◽  
2011 ◽  
Vol 77 (13) ◽  
pp. 1253-1262 ◽  
Author(s):  
S. Salloway ◽  
R. Sperling ◽  
R. Keren ◽  
A. P. Porsteinsson ◽  
C. H. van Dyck ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Randomized Trial ◽  
Phase 2

The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761(R) for prevention of Alzheimer disease in patients over 70 with a memory complaint

Neurology ◽  
2006 ◽  
Vol 67 (Issue 9, Supplement 3) ◽  
pp. S6-S11 ◽  
Author(s):  
B. Vellas ◽  
S. Andrieu ◽  
P. J. Ousset ◽  
M. Ouzid ◽  
H. Mathiex-Fortunet ◽  
...  
Keyword(s):  
Alzheimer Disease ◽  
Randomized Trial ◽  
Egb 761 ◽  
Methodological Issues ◽  
Double Blind ◽  
Memory Complaint
Sign in / Sign up

Export Citation Format

Share Document